ReCerise Therapeutics Inc. ("ReCerise"), a company committed to research and development of first-in-class therapeutics in oncology, recently entered a research partnership with the National Cancer ...

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

Enterprises across Europe are increasingly turning to managed network services providers to advance their digital transformation agendas, according to a new research report published today by ...

The home improvement retailer has its sights set on a particular cohort.